Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel antifungal potential protein of Bacillus subtilis-fermented Gracilaria agar-processing wastewater: identification, mechanism, regulation and applications in citrus protection.

Food microbiology·2026
Same author

Unveiling the landscape of Mottness and its proximity to superconductivity in 4Hb-TaS<sub>2</sub>.

Nature communications·2026
Same author

Genetic variation, recombinant characteristics, and seroprevalence analysis of echovirus 3 causing severe and mild cases of hand, foot, and mouth disease in Guizhou Province.

Microbiology spectrum·2026
Same author

Baicalein mitigates anti-tuberculosis-induced liver injury via inhibition of lipid peroxidation mediated by ferritinophagy and ferroptosis: Involvement of Yap 1/NCOA4 signaling.

Biochimica et biophysica acta. Molecular basis of disease·2026
Same author

Trigger-day hCG effects on DNA methylation and neurodevelopment in ART offspring.

Nature communications·2026
Same author

Preclinical Evaluation of a Phage T4-Based Multi-Epitope Nanoparticle Vaccine Against Porcine Epidemic Diarrhea Virus.

Transboundary and emerging diseases·2026

Related Experiment Video

Updated: Jul 5, 2025

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
06:18

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

14.3K

Loop-mediated isothermal amplification linked a nanoparticles-based biosensor for detecting Epstein-Barr virus.

Xinggui Yang1, Xiaoyan Zeng2, Junfei Huang1

  • 1Guizhou Provincial Center for Disease Control and Prevention, Guiyang, 550004, Guizhou, People's Republic of China.

Applied Microbiology and Biotechnology
|January 12, 2024
PubMed
Summary

A new diagnostic platform, EBV-LAMAD, rapidly detects Epstein-Barr virus (EBV) using loop-mediated isothermal amplification and a gold nanoparticles biosensor. This simplified assay offers sensitive and reliable EBV infection screening, especially for resource-limited settings.

Keywords:
DiagnosisEBV-LAMADEpstein-Barr virusGold nanoparticles–based lateral flow biosensorsLoop-mediated isothermal amplification

More Related Videos

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
05:34

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Published on: September 8, 2023

764
Visual Detection of Multiple Nucleic Acids in a Capillary Array
08:56

Visual Detection of Multiple Nucleic Acids in a Capillary Array

Published on: November 15, 2017

7.3K

Related Experiment Videos

Last Updated: Jul 5, 2025

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
06:18

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

14.3K
Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
05:34

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Published on: September 8, 2023

764
Visual Detection of Multiple Nucleic Acids in a Capillary Array
08:56

Visual Detection of Multiple Nucleic Acids in a Capillary Array

Published on: November 15, 2017

7.3K

Area of Science:

  • Virology
  • Biotechnology
  • Medical Diagnostics

Background:

  • Epstein-Barr virus (EBV) establishes lifelong latent infections in B lymphocytes.
  • Accurate and rapid diagnostic tools are crucial for managing EBV infections.

Purpose of the Study:

  • To develop a rapid, sensitive, and reliable diagnostic platform for Epstein-Barr virus (EBV) detection.
  • To create a simplified assay suitable for clinical settings, including resource-limited regions.

Main Methods:

  • Development of a novel loop-mediated isothermal amplification (LAMP) assay targeting the EBNA-LP gene.
  • Integration of LAMP with a gold nanoparticles-based lateral flow biosensor (AuNPs-LFB) for detection (EBV-LAMAD).
  • Optimization and validation of the EBV-LAMAD assay using various pathogen and whole blood samples.

Main Results:

  • The EBV-LAMAD assay demonstrated a limit of detection (LoD) of 45 copies/reaction.
  • The assay successfully detected representative EBV pathogens without cross-reactivity with other organisms.
  • The entire workflow, from sample preparation to detection, was completed within 70 minutes.

Conclusions:

  • The EBV-LAMAD assay is a rapid, simplified, sensitive, and reliable method for EBV detection.
  • This assay presents a competitive diagnostic and screening tool for EBV infection in clinical settings.
  • The EBV-LAMAD assay is particularly advantageous for basic laboratories in resource-limited areas.